Commission Implementing Regulation (EU) 2018/1967 of 12 December 2018 amending Regulation (EU) No 37/2010 to classify the substance paromomycin as regards its maximum residue limit (Text with EEA relevance.)

• CELEX: Implementing Regulation (EU) 2018/1967
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

It shall apply from 11 February 2019.

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘paromomycin’ is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

‘Paromomycin

Paromomycin

All food producing species

500 μg/kg

Muscle

For fin fish the muscle MRL relates to ‘muscle and skin in natural proportions’.

MRLs for liver and kidney do not apply to fin fish.

Not for use in animals from which milk is produced for human consumption.

Anti-infectious agents/Antibiotics’

1 500 μg/kg

Liver

1 500 μg/kg

Kidney

200 μg/kg

Eggs